Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Most skin conditions can be managed with general medical knowledge.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

A neck lesion misdiagnosed as benign was later treated successfully with Mohs Micrographic Surgery.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

CEC levels may be a useful marker for predicting prostate cancer progression.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Overexpressing ornithine decarboxylase and v-Ha-ras in keratinocytes leads to invasiveness and malignancy.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Comma hairs are a new sign for identifying scalp fungal infections.